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Abstract
Atherosclerosis is a chronic inflammatory disease characterized by the accumulation of lipids and
inflammatory cells along the inner walls of arteries, and is an underlying cause of cardiovascular
disease. Atherosclerotic lesions develop predominantly at branches, bends, and bifurcations in the
arterial tree because these sites are exposed to low or disturbed blood flow, which exerts low/
oscillatory shear stress on the vessel wall. This mechanical environment alters endothelial cell
physiology by enhancing inflammatory activation. In contrast, regions of the arterial tree that are
exposed to uniform, unidirectional blood flow and experience high shear stress are protected from
inflammation and lesion development. Shear stress is sensed by the endothelium via mechan-
oreceptors and is subsequently transduced into biochemical signals resulting in modulation of
proinflammatory signaling pathways. In this article, we address the molecular mechanisms behind the
spatial localization of vascular inflammation and atherosclerosis, with particular focus on studies by
our own group of two key proinflammatory signaling pathways, the mitogen-activated protein kinase
pathway and the nuclear factor-kappa-B pathway.
Introduction and context
Cardiovascular disease accounts for the greatest number
of deaths worldwide and currently presents a major
burden to health services and society. This burden is set to
increase as obesity and diabetes, two major risk factors
for the disease, reach epidemic levels. Most resources
are currently directed towards surgical intervention and
management of advanced cardiovascular disease, but
clearly prevention would be preferable. Encouraging
lifestyle changes is expected to play a major role in
slowing disease progression; however, greater under-
standing of the disease at the molecular level is of critical
importance in informing future treatment strategies and
aiding disease prevention.
The build up of atherosclerotic plaques within the arterial
tree is the underlying cause of most forms of cardiovas-
cular disease, including coronary artery disease and stroke.
Atherosclerosis is a lipid-driven chronic inflammatory
disease in which inflammatory cells, lipids, and extra-
cellular matrix (ECM) accumulate within the artery wall to
form plaques which reduce, and may eventually shut
down, blood flow through the artery, with devastating
consequences for the tissue or organ it supplies. A critical
step in lesion formation is the oxidative modification of
circulating low-density lipoprotein (LDL) by reactive
oxygen species. Oxidized LDL promotes the recruitment
of leukocytes from the bloodstream to the arterial wall by
triggering the expression of adhesion proteins, chemo-
kines, and other proinflammatory molecules on endothe-
lial cells (such as vascular cell adhesion molecule-1
[VCAM-1] and E-selectin, illustrated in Figure 1). ECM
remodeling and alterations in ECM composition during
atherogenesis can stimulate proliferation and migration
of smooth muscle cells and promote proinflammatory
signaling, contributing to the development of the
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plaque [1]. There is also evidence that endothelial cell
apoptosis plays a role in plaque formation, potentially by
increasing the permeability of the arterial wall to LDL [2].
Although a wide range of global risk factors such as age,
high cholesterol, and obesity significantly increase
the risk of developing atherosclerosis, plaque formation
occurs predominately at specific sites within the arterial
tree, suggesting a critical role for local factors within the
vasculature. Atherosclerotic plaques are mainly found at
arterial bifurcations and branch points and areas of
vessel curvature whereas straight unbranching segments
of artery are generally spared. Several molecular mechan-
isms that influence the localization of plaque formation
have been described recently and will be explored within
this article.
It was recognized by Caro et al. [3] in 1969 that sites of
lesion development were associated with regions of
altered blood flow, leading to the suggestion that flow-
regulated mechanical forces could play a key role in
lesion development. Two hypotheses emerged to
account for this effect: the mass transport theory and
the shear stress theory of atherosclerosis (depicted in
Figure 2).
The mass transport theory of atherosclerosis
One possible explanation for the accumulation
of atheromatous material at sites of low or disturbed
blood flow is that an increased rate of uptake of bioactive
substances (e.g., LDL, oxygen, nitric oxide) from the blood
stream into the vessel wall results from the increased
length of time the blood is in contact with the vessel wall
in such areas, particularly in areas of flow stagnation. This
idea is supported by a wealth of experiments in animals
that have demonstrated greater uptake of labeled macro-
molecules such as albumin in regions of low blood flow
that are susceptible to the development of atherosclerosis
[4]. Low or disturbed blood flow might also enhance
atherogenesis due to altered transport of leukocytes from
the bloodstream to the endothelial surface.
The shear stress theory of atherosclerosis
The endothelium is in direct contact with flowing blood
and hence it is constantly exposed to the mechanical
forces that the blood exerts. The drag force exerted by
flow on the vessel wall, called shear stress, is a critical
factor inmaintaining endothelial function and varies with
time, magnitude, and direction, according to vascular
pulsatility and anatomy. Relatively straight, unbranched
arteries are exposed to uniform, unidirectional flow and
Figure 1. Leukocyte adhesion and transmigration
Proinflammatory signaling results in the increased expression of adhesion molecules such as E-selectin on endothelial cells, which facilitates “capture” of the
leukocytes to the vessel wall. Chemokines secreted by endothelial cells activate leukocyte integrins, a process that promotes firm adhesion between
leukocytes and endothelial cells via integrin-adhesion molecule interactions. Adherent leukocytes subsequently transmigrate through the endothelium to the
underlying tissue. E-selectin, endothelial selectin; ICAM-1, intercellular adhesion molecule-1; IL-8, interleukin 8; MCP-1, monocyte chemotactic protein-1;
VCAM-1, vascular cell adhesion molecule-1.
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experience relatively high shear stress (time-averaged
mean value approximately 150 µN/cm2; equivalent to
15 dynes/cm2). By contrast, at vessel bifurcations and
bends, the flow is disturbed and changes direction
during the cardiac cycle resulting in relatively low and/
or oscillatory shear stress (time-averaged mean <50 µN/
cm2; equivalent to <5 dynes/cm2) [5].
Atherosclerosis preferentially develops in regions of flow
disturbance and separation, where shear stress is signifi-
cantly lower in magnitude and exhibits directional
variations [3]. Thus low shear stress provides predisposi-
tion for atherogenic transformation by contributing to
endothelial dysfunction whereas high shear areas might
shield against atherosclerosis by enhancing endothelial
protection.
For shear stress to influence endothelial cell function, the
cell must be able to sense, and then convert, mechanical
forces into biochemical signals that alter physiology.
Amechanosensory complex on the endothelial cell surface
has been identified as an initial transducer of mechanical
forces consisting of the adhesion molecules PECAM-1
(platelet endothelial cell adhesion molecule-1), which
is the mechanosensor, and VE-cadherin and VEGFR-2
(vascular endothelial growth factor receptor-2), which,
once activated, stimulate a host of downstream signaling
pathways. Mechanotransduction via this trimolecular
complex mediates integrin activation, which causes
elongation and alignment of cells in the direction of
flow, characteristic of cells in high-shear, protected regions
[6]. This is an adaptive response that redistributes and
reduces the local mechanical load experienced by the
cell, reducing subsequent injury, and is dependent on
anchoring of endothelial cells to the ECM via integrins.
High laminar shear stress induces rapid conformational
activation of integrins leading to remodeling of endo-
thelial attachment sites and increased binding to the
ECM, triggering cytoskeletal rearrangement and cell
alignment [7].
High shear stress is anti-inflammatory, antiproliferative,
antiapoptotic, antithrombotic, and also protective
against intracellular endoplasmic reticulum stress [8],
which collectively may confer some degree of protection
from lesion formation. Here, we focus on the molecular
mechanisms that underlie the modulation of inflamma-
tory activation by shear stress.
Shear stress regulates endothelial activation
Studies of cultured endothelial cells have revealed that
prolonged unidirectional high shear stress suppresses
proinflammatory activation and leukocyte recruitment
in response to an inflammatory stimulus, for example,
tumornecrosis factor-alpha (TNF-a) [9,10]. This observation
is supported by in vivo studies where endothelial cells at
low shear, atherosusceptible sites express proinflamma-
tory markers. In contrast, proinflammatory signaling is
suppressed in regions of the arterial tree that are protected
from atherosclerosis and exposed to high shear stress
[11-14].
Understanding the mechanisms by which high shear
stress reduces proinflammatory signaling is an area
of active research. In vitro and in vivo studies have
revealed a plethora of genes that are altered by shear
stress, albeit with a wide disparity between studies,
which can be attributed to the different cell types
studied and variation in magnitude, direction, and
duration of shear stress. Nevertheless, two key proin-
flammatory signaling pathways: the mitogen-activated
protein kinase (MAPK) pathway and nuclear factor-
kappa-B (NF-kB) pathway have been identified as being
differentially regulated at protected and susceptible
sites of the arterial tree [12,15,16]. It is likely that both
contribute to inflammation and lesion development at
susceptible sites since several proinflammatory genes
Figure 2. Atherosclerotic plaques occur at sites of low/disturbed
blood flow
Atherosclerotic lesions form predominantly at regions of the arterial tree
exposed to low/disturbed blood flow such as branches, bends, and
bifurcations, whilst regions exposed to unidirectional high flow are spared.
Two theories have been proposed that account for this localization: (1) the
mass transport theory, where atherogenic material such as low-density
lipoprotein (LDL) and leukocytes have better access to the arterial wall in
areas of low flow or stagnation; and (2) the shear stress theory, where shear
stress (mechanical drag) is sensed by endothelial cells, resulting in an altered
phenotype. Low/oscillatory shear stress primes endothelial cells for
inflammation by inducing adhesion molecule expression.
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implicated in atherosclerosis (e.g., the genes encoding
VCAM-1, E-selectin, and IL-8) require the activation of
both pathways for transcription to occur. High laminar
shear stress suppresses inflammation in part by
modulating or inhibiting NF-kB and MAPK signaling,
and the underlying mechanisms are discussed in this
article.
The MAPK Pathway
The MAPKs are a group of highly conserved serine/
threonine protein kinases that play an important role in
many cellular processes including apoptosis, proliferation,
and inflammation. The three well characterized MAPK
pathways are the c-Jun N-terminal kinase (JNK), the p38,
and the extracellular signal-regulated kinase (ERK) path-
ways. The JNK and p38 pathways are preferentially
activated by inflammatory cytokines and stress, whereas
the ERK pathway is preferentially activated by growth
factors. Typically, activation ofMAPK pathways is initiated
by proinflammatory mediators via activation of a cell
surface receptor, activating a chronological phosphoryla-
tion cascade. Activation of JNK and p38 requires the
activity of upstream MAPK kinases (MAPKKs, e.g., MKK3
and MKK6) and MAPK kinase kinases (MAPKKKs, e.g.,
apoptosis signal-regulating kinase-1 [ASK-1] and TGF-b
activated kinase-1 [TAK-1]). Active, phosphorylated forms
of JNK and p38 activate transcription factors belonging to
the activating protein-1 (AP-1) superfamily (including c-
Jun and activating transcription factor-2 [ATF2]), which
drives transcription of proinflammatory genes such as
VCAM-1. Proinflammatory MAPK activation has been
linked to the development of atherosclerotic lesions, as
increased levels of phosphorylated nuclear ATF-2 have
been observed in human atherosclerotic plaques [16]. We
have also found increased activities of JNK and p38 at
atherosusceptible sites in murine aorta along with
increased expression of VCAM-1, indicative of a proin-
flammatory phenotype [14].
Proinflammatory signaling also induces MAPK phos-
phatase-1 (MKP-1), a negative regulator of the MAPK
pathway that inactivates p38 and JNK by removing
phosphate groups, which may serve to limit the
inflammatory response. It is clear that shear stress is an
important factor in determining the expression pattern of
MKP-1 because exposing cultured cells to unidirectional
high shear stress produced amarked induction of MKP-1.
We also demonstrated that MKP-1 dampens proinflam-
matory signaling since silencing MKP-1 function in
cultured endothelial cells increased p38 activation and
enhanced VCAM-1 expression in response to shear stress.
Deletion of MKP-1 using anMKP-1 knockout mouse also
revealed increased activity of JNK and p38 and increased
expression of VCAM-1 in protected regions of the mouse
aorta. Our findings present a novel molecular mechan-
ism contributing to the spatial distribution of vascular
inflammation and atherosclerosis, where high shear
stress protects arteries from inflammation by inducing
persistent endothelial expression of MKP-1, which
suppresses the activities of p38 and JNK [14].
Other reports have identified several other intermedi-
aries in the JNK/p38 MAPK pathway that are negatively
regulated by shear stress and that may also serve to
dampen proinflammatory signaling in regions of high
shear stress. In cultured cells, for example, exposure to
high laminar shear stress reduces the activation of ASK-1
(a MAPKKK) by promoting association with its inhibi-
tory binding protein, depicted in Figure 3 [17]. High
shear stress also reduces JNK activity by blocking
cleavage of protein kinase C epsilon (PKCζ) [18,19]. In
addition, the influence of shear stress on JNK activation
may be influenced by the nature of the subendothelial
matrix [20], underlying the complex interplay of flow-
regulated and inflammatory signaling pathways.
In subsequent studies we have found that nuclear factor
erythroid 2-related factor (Nrf2), an antioxidant (protec-
tive) transcription factor, is preferentially activated by high
shear stress and may be atheroprotective via negative
regulation of the MAPK pathway [21]. In unstimulated
cells, Nrf2 is suppressed by binding to kelch-like ECH-
associated protein-1 (Keap-1), which targets it for
ubiquitination and degradation by the proteasome.
Upon stimulation, this interaction is disrupted, leading
to dissociation from Keap-1. This results in stabilization
and accumulation ofNrf2 and translocation to the nucleus
where Nrf2 can induce the expression ofmany antioxidant
genes (e.g., those encoding hemeoxygenase-1, glutathione
S-transferase, and ferritin).
Given the important role of oxidative mechanisms in
vascular inflammation, we recently studied the role of
Nrf2 in regulating endothelial activation. We found that
Nrf2 is activated in regions of the mouse aorta exposed
to unidirectional high shear stress and protected from
atherosclerosis. Only inactive cytoplasmic forms of Nrf2
could be detected in the inner curvature, an area of low/
oscillatory shear stress and susceptible to inflammation
and lesion formation. In mice lacking Nrf2, both
p38 activity and VCAM-1 expression were significantly
increased in the protected region, suggesting that Nrf2
blocks proinflammatory signaling in regions of high
shear stress. Parallel in vitro studies confirmed this,
where application of unidirectional high shear stress to
cultured cells significantly enhanced expression and
nuclear activity of Nrf2 with a simultaneous reduction
in VCAM-1 expression. We propose that Nrf2 suppresses
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endothelial activation by targeting the MAPK signaling
pathway at two levels: by reducing MKK3/6 signaling to
p38 and by enhancing the activity of MKP-1. Expression
levels of these intermediaries are not altered, rather Nrf2
facilitates increased activity by influencing their redox
state; Nrf2 promotes an antioxidant environment that
favors the reduced form of MKP-1, which has greater
catalytic activity [21]. Thus our studies reveal that Nrf2 is
a key determinant of the spatial differences in inflamma-
tion and atherosclerosis. Interestingly, genetic deletion of
Nrf2 did not completely restore proinflammatory
activation at the protected site, suggesting that Nrf2
works in concert with other anti-inflammatory mole-
cules to inhibit inflammation at sites of high shear stress.
The NF-kB pathway
The transcription factor NF-kB has been closely linked
with cardiovascular health and disease due to its control
of multiple processes including immunity, inflammation,
cell survival, differentiation and proliferation, and regula-
tion of cellular responses to stress, hypoxia, stretch, and
ischemia. NF-kB signaling in endothelial cells typically
leads to the expression of genes that induce recruitment of
inflammatory cells to the vessel wall, including ICAM-1
(intercellular adhesion molecule-1), VCAM-1, E-selectin,
and cytokines such as TNF-a and IL-1. NF-kB is composed
of two subunits, with the p50-p65(RelA) heterodimer
most abundant in endothelial cells. In the absence of a
stimulus, NF-kB is bound to an inhibitory molecule, IkB,
which masks its nuclear localization sequence and
sequesters it in the cytoplasm. NF-kB is activated by
several signaling pathways that cause it to be released
from IkB, mostly via activation of an IkB kinase (IKK),
which phosphorylates IkB, leading to its ubiquitination
and subsequent degradation by the proteasome. Once the
heterodimer is released, the nuclear localization sequence
permits translocation to the nucleus and binding to
target sequences on the genome. NF-kB may also itself be
Figure 3. Inflammatory signaling pathways that are regulated by high shear stress
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Both the mitogen-activated protein kinase (MAPK) and nuclear factor-kappa-B (NF-kB) signaling pathways are active at sites of the arterial tree exposed to
low/oscillatory shear stress and are stimulated by proinflammatory cytokines leading to inflammation and lesion development. At sites of high shear stress,
these signaling pathways are inhibited at several levels with a consequent inhibition of inflammation. AP-1, activating protein-1; ASK-1, apoptosis signal-
regulating kinase 1; ICAM-1, intercellular adhesion molecule-1; IkB, inhibitory kB; IKK, IkB kinase; JNK, c-Jun N-terminal kinase; KLF-2, Krüppel-like factor-2;
MKP-1, MAPK phosphatase-1; MKK, MAPK kinase; Nrf2, nuclear factor erythroid 2-related factor; Ox-LDL, oxidized low-density lipoprotein; P,
phosphorylation; PKCζ, protein kinase C epsilon; TAK-1, transforming growth factor (TGF)-b activated kinase 1; VCAM-1, vascular cell adhesion molecule-1;
Uq, ubiquitin.
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phosphorylated, which facilitates DNA binding and
transcription, but its activity is tightly regulated by
negative feedback loops that limit the duration of nuclear
localization and hence transcriptional activity. This relies
on NF-kB-dependent transcription of IkBa, which con-
tains a nuclear export sequence, and by binding to NF-kB
serves to remove it from the nucleus. Also, activation of
the deubiquitinating enzymes A20 and Cezanne by
proinflammatory signaling molecules blocks IKK activa-
tion and prevents release of NF-kB from IkB [22,23].
ActiveNF-kBhas been identified in atherosclerotic plaques
and early lesions along with many NF-kB regulated
molecules, indicating that it is instrumental in atherogen-
esis. One significant study demonstrated reduced inflam-
mation and plaque formation in atherosclerosis-prone
cholesterol-fed mice lacking endothelial expression of
IKKg, supporting the idea that NF-kB-mediated proin-
flammatory gene expression plays a causal role in lesion
development [24]. Studies in “healthy” mice and pigs
revealed that the expression of NF-kB subunits and
regulatory components (p65, IkBa, and IkBb) is signifi-
cantly increased in regions of the aorta exposed to low
shear stress compared to high shear stress [11,12].
Expression was, however, restricted to the cytoplasm,
indicating that NF-kB was inactive. This suggests that cells
exposed to low shear stress are primed for activation upon
challenge with a proinflammatory stimulus due to an
increased expression of NF-kB subunits [11]. Studies in
pigs also showed a reduced expression of negative
regulators that switch off NF-kB activity (e.g., Cezanne)
at the atherosusceptible site [12]. We have subsequently
shown that the expression of Cezanne is shear-sensitive
and is increased by unidirectional laminar shear stress
[22].
NF-kB transcription factors have the potential to exert
dual functions since they can be both antiapoptotic
(protective) and proinflammatory. Our own studies,
using a parallel plate flow chamber, demonstrated that
high laminar shear stress enhanced NF-kB-mediated
induction of several antiapoptotic genes, such as BCL2,
A20 (TNFAIP3), A1 (BCL2A1), and MnSOD (SOD2),
whilst simultaneously dampening proinflammatory acti-
vation in response to a proinflammatory stimulus, TNF-a
[10]. We therefore conclude that high shear stress can
influence the function of NF-kB by affecting the balance of
induction of inflammatory and antiapoptotic genes. Thus
endothelial cells at low shear regions are prone to
inflammatory activation via multiple mechanisms that
influence both the expression and activity of NF-kB.
Numerous studies have shown a specific induction of
Krüppel-like factor-2 (KLF-2) in response to laminar
shear stress and have placed KLF-2 as a key regulator of
shear-responsive transcripts and a mediator of the
atheroprotective effects of high shear stress [15,25,26].
KLF-2 has been shown to attenuate endothelial activa-
tion and leukocyte migration in cultured endothelial
cells by inhibiting the expression of proinflammatory
genes such as those encoding VCAM-1 and E-selectin.
The suppressive effects of KLF-2 on inflammatory
activation were attributed to its ability to sequester
critical coactivators of NF-kB, cyclic AMP response
element-binding protein (CBP) and p300, thereby
reducing NF-kB mediated transcription [15].
Anton Horrevoet’s group have shown that KLF-2 may
also reduce proinflammatory gene expression by inhibit-
ing the MAPK pathway. They demonstrated that KLF-2
inhibits nuclear localization of the ATF-2 transcription
factor thereby reducing transcription from AP-1 promo-
ter sites. Similarly, knockdown of KLF-2 with small
interfering RNA caused a marked reduction in proin-
flammatory gene expression in cells without flow [16].
Subsequent studies revealed that KLF-2 inhibits the
phosphorylation of JNK, an effect that is dependent on
the actin cytoskeleton [27]. Work from this group has
also shown that KLF-2 is able to potentiate the
atheroprotective effects of flow-induced Nrf2 by enhan-
cing its nuclear translocation and activation [28],
indicating that these central regulators of the anti-
inflammatory effects of shear stress may work in synergy
to modulate the transcriptome.
Implications for therapeutic strategies to prevent
or treat atherosclerosis
It is clear that both the MAPK pathway and the NF-kB
pathway play a significant role in endothelial activation
at atherosusceptible sites and that high shear stress is
able to suppress activation of these pathways and protect
against lesion development (summarized in Figure 3).
KLF-2 and Nrf2 have been identified as central transcrip-
tional regulators of the physiological response to shear
stress and are of major interest since pharmacological
manipulation could potentially be used to reduce
vascular inflammation at atherosusceptible sites and
hence slow or prevent lesion formation to reduce
morbidity of cardiovascular disease. To this effect, we
recently demonstrated that sulforaphane, a naturally
occurring organic compound that acts as an antioxidant
and is derived in high quantities from broccoli, water-
cress, and other green vegetables, has atheroprotective
actions. We found that sulforaphane, at a relatively low
concentration, can reduce inflammatory activation of
endothelial cells at atherosusceptible sites by increasing
Nrf2 activity via inhibition of Keap-1 [21]. Thus
sulforaphane is an example of a targeted therapeutic
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intervention that enhances expression of protective, anti-
inflammatory transcripts at atherosusceptible sites and
may, in the future, have clinical utility for the prevention
or treatment of cardiovascular inflammation. Since
sulforaphane can be found in abundance in many
green vegetables, this finding is consistent with the
concept that eating broccoli and other green vegetables
can lower the risk of atherosclerosis.
Several groups have recently studied the effects of statins
(cholesterol-lowering drugs) on endothelial physiology
and observed that statins, independently of their lipid-
lowering actions, can suppress numerous inflammatory
genes via the induction of KLF-2 [29,30]. Interestingly,
exposure of endothelial cells to laminar shear stress
enhanced the responsiveness of endothelial cells to
statins, whereas exposure to disturbed blood flow had
the opposite effect [31]. These data highlight the influence
of mechanical forces on vascular responses to pharmaco-
logical agents and suggest that statins may preferentially
influence high-shear regions of the arterial tree.
Conclusions
Genome-wide approaches are now required to further
define the molecular mechanisms that control the spatial
distribution of vascular inflammation and atherogenesis.
Analysis of the endothelial transcriptome at sites of
low/oscillatory and high shear stress will reveal specific
transcripts that are differentially regulated in response
to shear stress and could, in time, be targeted for
pharmacological manipulation. This approach will also
shed light on the mechanisms by which shear stress
modulates endothelial apoptosis, proliferation, and
thrombogenicity, all of which contribute to the pathogen-
esis of atherosclerosis. Better understanding of these
mechanisms will enable targeted therapeutic interven-
tions that promote a protective phenotype in atherosus-
ceptible regions in order to slow or even halt the
progression of cardiovascular disease.
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